That’s the what I was expecting to hear. Maybe I

That’s the what I was expecting to hear. Maybe I’m too optimistic, maybe we don’t know something about manufacturing?

This has been a concern all along for Dr L perspective, I won’t forget him saying that. I agree, but I just hope that NP isn’t being completely transparent because he can’t tell shareholders everything.

I guess what I’m saying is I have hope that the FDA is working side by side with us and looking at this problem as well and might have some sort of solution that we didn’t think of? No clue just a guess.

I just hope the FDA doesn’t drop the ball, but I guess I won’t be surprised.

We haven’t had any updates on AGC right?

Daniel Rizzo
Founder & CEO | FireGate Biotech™
AI Platform: Lux Veritas™

Federal Whistleblower Case References
• HHS & SEC Whistleblower ID – HL-1412396
• DOJ Investigation Report / Whistleblower ID – 20250705-0001
• NIH Case Reference – CS1137565 ( IC IG / 50 U.S.C. § 3033 )

Website: FireGateBiotech.com
(For official updates and correspondence — I will no longer be posting here or responding via DMs)

Contact FireGate Biotech


— Jeremiah 51:36